The transcription factor Kruppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma

被引:25
|
作者
An, Tingting [1 ]
Dong, Tianxiu [1 ]
Zhou, Haoxin [2 ]
Chen, Yaodong [1 ]
Zhang, Jiuwei [1 ]
Zhang, Yu [1 ]
Li, Zizhuo [1 ]
Yang, Xiuhua [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Abdominal Ultrasound, 23 Youzheng St, Harbin 150001, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Emergency Surg, Harbin 150001, Heilongjiang, Peoples R China
关键词
Kruppel-like factor 5; Hepatocellular carcinoma; Proliferation; Migration; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-METASTASIS; CANCER CELLS; KLF5; APOPTOSIS; PATHWAY; PROLIFERATION; INVASION;
D O I
10.1016/j.bbrc.2018.11.084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor Kruppel-like factor 5 (KLF5) is highly expressed in many cancers and serves as a prognostic factor. However, the function of KLF5 in hepatocellular carcinoma (HCC) is unclear. In this study, we found that KLF5 was significantly overexpressed in HCC cell lines and specimens, and high KLF5 expression predicted a poor prognosis for HCC patients. Then, we studied the effects of KLF5 on the proliferation, apoptosis, migration and invasion of HCC cells in vitro and vivo. The inhibition of KLF5 markedly inhibited HCC growth and metastasis, while KLF5 overexpression promoted these processes. In addition, we observed that KLF5 could promote the epithelial-mesenchymal transition (EMT) in HCC via the PI3K/AKT/Snail signaling pathway. The silencing of KLF5 in HCC cell lines downregulated the expression of N-cadherin, Vimentin and Snail and increased the expression of the epithelial marker E-cadherin. The expression of MMP2 and MMP9 was also decreased in KLF5-silenced HCC cells. However, opposite results were observed in the KLF5-overexpressing group. These results indicate that KLF5 plays a significant role in HCC progression and metastasis and induces EMT via activating PI3K/AKT/Snail signaling, and the inhibition of KLF5 may be a potential treatment modality for patients with HCC. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:159 / 168
页数:10
相关论文
共 50 条
  • [41] HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
    Hongqiang Wang
    Xuchun Yang
    Yan Guo
    Lin Shui
    Shi Li
    Yifeng Bai
    Yu Liu
    Ming Zeng
    Jianling Xia
    Journal of Experimental & Clinical Cancer Research, 38
  • [42] HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
    Wang, Hongqiang
    Yang, Xuchun
    Guo, Yan
    Shui, Lin
    Li, Shi
    Bai, Yifeng
    Liu, Yu
    Zeng, Ming
    Xia, Jianling
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [43] LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway
    Wu, J. -H.
    Tian, X. -Y.
    An, Q-M.
    Guan, X. -Y.
    Hao, C. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1645 - 1652
  • [44] PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway
    Zhao, Gang
    Shi, Xiaobao
    Sun, Zhanbo
    Zhao, Pengfei
    Lu, Zaiming
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53 (12) : 1602 - 1613
  • [45] APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target
    Chen, Huarong
    Wong, Chi-Chun
    Liu, Dabin
    Go, Minnie Y. Y.
    Wu, Bin
    Peng, Sui
    Kuang, Ming
    Wong, Nathalie
    Yu, Jun
    THERANOSTICS, 2019, 9 (18): : 5246 - 5260
  • [46] PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling
    Peng, Xing-Si
    Yang, Jun-Ping
    Qiang, Yuan-Yuan
    Sun, Rui
    Cao, Yun
    Zheng, Li-Sheng
    Peng, Li-Xia
    Lang, Yan-Hong
    Mei, Yan
    Li, Chang-Zhi
    Meng, Dong-Fang
    Liu, Zhi-Jie
    Wang, Ming-Dian
    Zhou, Fang-Jian
    Huang, Bi-Jun
    Qian, Chao-Nan
    MOLECULAR CANCER RESEARCH, 2020, 18 (06) : 903 - 912
  • [47] The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma
    Jin-lan Huang
    Shun-wang Cao
    Qi-shui Ou
    Bin Yang
    Shi-hao Zheng
    Jing Tang
    Jing Chen
    Yan-wei Hu
    Lei Zheng
    Qian Wang
    Molecular Cancer, 17
  • [48] The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma
    Huang, Jin-lan
    Cao, Shun-wang
    Ou, Qi-shui
    Yang, Bin
    Zheng, Shi-hao
    Tang, Jing
    Chen, Jing
    Hu, Yan-wei
    Zheng, Lei
    Wang, Qian
    MOLECULAR CANCER, 2018, 17
  • [49] ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway
    Xing, Yanwei
    Ren, Shuo
    Ai, Lianjie
    Sun, Weidong
    Zhao, Zhiwei
    Jiang, Fengqi
    Zhu, Yuekun
    Piao, Daxun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (05) : 1691 - 1703
  • [50] Activating transcription factor 2 promotes the progression of hepatocellular carcinoma by inducing the activation of the WHSC1-mediated TOP2A/PI3K/AKT axis
    Bao, Zhong-Ming
    Yao, Dan
    Qian, Xu
    Zhang, Hua-Guo
    Yang, Ming
    Guo, Yun-Hu
    Qin, Lei
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2022, 38 (07): : 662 - 674